Andy Studna

In episode 108, the rest of the PharmExec editorial staff join Elaine and Miranda as they announce and give more insight into the profiles they've written about the eleven members of our 2022 Emerging Pharma Leaders.

An entrepreneurial quest to transform oncology treatment.

Fast riser in biotech strategy execution seizes on opportunities in immunotherapy.

Standard for reaching patients shifts with influx of new technology in post-COVID world.

Looking Back at 2011–2014.

Hopeful new standard of care for advanced prostate cancer capitalizing on momentum.